Europe Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type, Treatment Type, Infection Severity, and End User

List of Tables

The Europe diabetic foot ulcer market was valued at US$ 1,837.31 million in 2022 and is expected to reach US$ 2,924.75 million by 2030; it is estimated to grow at a CAGR of 6.0% from 2022 to 20 30.

High Prevalence of Diabetes and Related Chronic Wounds Fuel the Europe Diabetic Foot Ulcer Market.

Diabetic patients are vulnerable to wounds, and the healing process is usually longer. Depending on healing timeframe, wounds are classified as acute and chronic. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes can lead to various complications in different body parts and increase the overall risk of premature death. According to the International Diabetes Federation (IDF), in 2021, there were ~ 537 million adults living with diabetes worldwide. The number is anticipated to increase to 643 million by 2030 and 783 million by 2045. Blood vessels and nerves in the feet of diabetic patients are prone to damages, resulting in numbness. Due to this, diabetic patients have a higher chance of developing diabetic foot ulceration.

According to a study published in 2021 in National Center for Biotechnology Information (NCBI), the risk of developing diabetic foot ulcers is between 19% and 34%. Approximately, a recurrence rate of 40% is experienced by patients within 1 year of recovery, 60% within 3 years, and 65% within 5 years. As per same study, it is reported that infection develops in 50-60% of ulcers and is the principal cause that damages diabetic feet. Thus, the demand for diabetic foot ulcer treatments is on rise globally, thereby fueling the market growth.

Europe Diabetic foot ulcer Market Overview

The Europe diabetic foot ulcer market is estimated to grow at a CAGR of 6.0% from 2022 to 2030. Key factors driving the market growth are increasing prevalence of diabetes and related chronic wounds and the rise in geriatric population propel market growth. The high cost of advanced wound care treatments hinders the market growth. However, initiatives taken by the European parliament in 2022 also adopted an ambitious motion for a diabetes resolution to focus on prevention, management, and better diabetes care in Europe. The resolution invites member states to develop, implement, and monitor national diabetes plans and strategies to ensure equitable treatment access, primary and secondary care, and diabetes education. The resolution calls for stronger European leadership and collaboration with member states to achieve these targets. Thus, these government initiatives are expected to boost the market growth.

The growing aging population is likely to contribute to the market growth as the aging population is susceptible to suffer from diabetes. According to the Office for National Statistics, the number of people aged 65 years and over increased from 9.2 million in 2011 to over 11 million in 2021 in the UK. Similarly, as per aarpinternational.org, Germany is one of five "super-aged" societies worldwide and will continue to grow. By 2050, one-third of its population will be 65 years or older. Therefore, the increasing prevalence of diabetes and the rising geriatric population in Europe will drive the diabetic foot ulcer market growth.

Europe Diabetic foot ulcer Market Revenue and Forecast to 2030 (US$ Million)

Europe Diabetic foot ulcer Market Segmentation

Based on treatment type , the Europe diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held largest share in 2022.

Based on ulcer type, the Europe diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held largest share in 2022.

Based on infection severity, the Europe diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held largest share in 2022.

Based on end user, the Europe diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held largest share in 2022.

Based on country, the Europe diabetic foot ulcer market is segmented into Germany, France, UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Molnlycke Health Care AB, and MiMedx Group Inc are some of the leading companies operating in the Europe diabetic foot ulcer market.

Product Code: BMIRE00029571

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Diabetic Foot Ulcer Market Landscape

4.1 Overview

5. Europe Diabetic Foot Ulcer Market - Key Industry Dynamics

5.1 Market Drivers:
- 5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
- 5.1.2 Surge in Geriatric Population
5.2 Market Restraints
- 5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
- 5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
- 5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:

6. Diabetic Foot Ulcer Market- Europe Market Analysis

6.1 Europe Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030

7. Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - by Treatment Type

7.1 Overview
7.2 Europe Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
- 7.3.1 Overview
- 7.3.2 Advanced Wound Care Dressings: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Alginate Dressings
  - 7.3.3.1 Overview
  - 7.3.3.2 Alginate Dressings: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Hydrofiber Dressings
  - 7.3.4.1 Overview
  - 7.3.4.2 Hydrofiber Dressings: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Foam Dressings
  - 7.3.5.1 Overview
  - 7.3.5.2 Foam Dressings: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Collagen Dressing
  - 7.3.6.1 Overview
  - 7.3.6.2 Collagen Dressing: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.7 Film Dressing
  - 7.3.7.1 Overview
  - 7.3.7.2 Film Dressing: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.8 Other Dressings
  - 7.3.8.1 Overview
  - 7.3.8.2 Other Dressing: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
- 7.4.1 Overview
- 7.4.2 Biologics: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Growth Factors
  - 7.4.3.1 Overview
  - 7.4.3.2 Growth Factors: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Skin Graft
  - 7.4.4.1 Overview
  - 7.4.4.2 Skin Graft: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
- 7.5.1 Overview
- 7.5.2 Therapy Device: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5.3 Negative Pressure Wound Therapy
  - 7.5.3.1 Overview
  - 7.5.3.2 Negative Pressure Wound Therapy: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5.4 Ultrasound Therapy
  - 7.5.4.1 Overview
  - 7.5.4.2 Ultrasound Therapy: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Diabetic Foot Ulcer market - Revenue and Forecast to 2030 - By Ulcer Type

8.1 Overview
8.2 Europe Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
- 8.3.1 Overview
- 8.3.2 Neuropathic Ulcers: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
- 8.4.1 Overview
- 8.4.2 Ischemic Ulcers: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
- 8.5.1 Overview
- 8.5.2 Neuro-ischemic Ulcers: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Infection Severity

9.1 Overview
9.2 Europe Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
- 9.3.1 Overview
- 9.3.2 Mild: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.3 Moderate: Europe diabetic foot ulcer market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.4 Severe: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By End User

10.1 Overview
10.2 Europe Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgical Centers: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
- 10.5.1 Overview
- 10.5.2 Home Care: Europe Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

11. Diabetic Foot Ulcer Market -Europe Country Analysis

11.1 Europe Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
- 11.1.1 Overview
  - 11.1.1.1 Europe Diabetic Foot Ulcer Market by Country
  - 11.1.1.2 Germany
    - 11.1.1.2.1 Germany Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.2.2 Germany Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.2.3 Germany Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.2.3.1 Germany: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.2.3.2 Germany: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.2.3.3 Germany: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.2.4 Germany Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.2.5 Germany Diabetic Foot Ulcer Market, by End User
  - 11.1.1.3 UK
    - 11.1.1.3.1 UK Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.3.2 UK Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.3.3 UK Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.3.3.1 UK: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.3.3.2 UK: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.3.3.3 UK: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.3.4 UK Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.3.5 UK Diabetic Foot Ulcer Market, by End User
  - 11.1.1.4 France
    - 11.1.1.4.1 France Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.4.2 France Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.4.3 France Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.4.3.1 France: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.4.3.2 France: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.4.3.3 France: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.4.4 France Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.4.5 France Diabetic Foot Ulcer Market, by End User
  - 11.1.1.5 Italy
    - 11.1.1.5.1 Italy Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.5.2 Italy Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.5.3 Italy Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.5.3.1 Italy: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.5.3.2 Italy: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.5.3.3 Italy: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.5.4 Italy Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.5.5 Italy Diabetic Foot Ulcer Market, by End User
  - 11.1.1.6 Spain
    - 11.1.1.6.1 Spain Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.6.2 Spain Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.6.3 Spain Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.6.3.1 Spain: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.6.3.2 Spain: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.6.3.3 Spain: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.6.4 Spain Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.6.5 Spain Diabetic Foot Ulcer Market, by End User
  - 11.1.1.7 Rest of Europe
    - 11.1.1.7.1 Rest of Europe Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.7.2 Rest of Europe Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.7.3 Rest of Europe Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.7.3.1 Rest of Europe: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.7.3.2 Rest of Europe: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.7.3.3 Rest of Europe: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.7.4 Rest of Europe Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.7.5 Rest of Europe Diabetic Foot Ulcer Market, by End User

12. Europe Diabetic Foot Ulcer Market Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Europe Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Europe Diabetic Foot Ulcer Market - Key Company Profiles

13.1 Convatec Group Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 3M Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Coloplast AS
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Smith & Nephew Plc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 B. Braun SE
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Molnlycke Health Care AB
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 MiMedx Group Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Medline Industries LP
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Organogenesis Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms